In vitro release and in vitro–in vivo correlation for silybin meglumine incorporated into hollow-type mesoporous silica nanoparticles
Xia Cao*, Wen-Wen Deng*, Min Fu*, Liang Wang, Shan-Shan Tong, Ya-Wei Wei, Ying Xu, Wei-Yan Su, Xi-Ming Xu, Jiang-Nan YuDepartment of Pharmaceutics, School of Pharmacy, and Center for Nano Drug/Gene Delivery and Tissue Engineering, Jiangsu University, Zhenjiang, People’s Republic of Chi...
Guardado en:
Autores principales: | Cao X, Deng WW, Fu M, Wang L, Tong SS, Wei YW, Xu Y, Su WY, Xu XM, Yu JN |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c3f21a580a074d27ba40dd5c868c7e87 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
In vitro biocompatibility of calcined mesoporous silica particles and fetal blood cells
por: Al Samri MT, et al.
Publicado: (2012) -
In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation
por: Xu Y, et al.
Publicado: (2012) -
In vitro evaluation of folic acid-conjugated redox-responsive mesoporous silica nanoparticles for the delivery of cisplatin
por: Alvarez-Berríos MP, et al.
Publicado: (2016) -
Synthesis and Characteristics of Double-Shell Mesoporous Hollow Silica Nanomaterials to Improve CO<sub>2</sub> Adsorption Performance
por: Jong-tak Lee, et al.
Publicado: (2021) -
Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum]
por: Xue H, et al.
Publicado: (2019)